000023195 000__ 01774cam\a22003855i\4500
000023195 001__ 23195
000023195 003__ SzGeWIPO
000023195 005__ 20240708161924.0
000023195 008__ 990714s1999\\\\xx\\\\\\r\\\\u000\0\eng\d
000023195 035__ $$a(wipo)(CD )99-1334
000023195 035__ $$a(OCoLC)1158555816
000023195 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000023195 043__ $$ae------
000023195 084__ $$a110$$qGB
000023195 1001_ $$aCook, Trevor M.,$$eauthor.
000023195 24510 $$aExperimental use as an exception to patent infringement /$$cTrevor M. Cook.
000023195 264_1 $$a[Place of publication not identified] :$$b[publisher not identified],$$c1999.
000023195 300__ $$a1 volume ([7] pages) ;$$c[28] cm.
000023195 336__ $$atext$$btxt$$2rdacontent
000023195 337__ $$aunmediated$$bn$$2rdamedia
000023195 338__ $$avolume$$bnc$$2rdacarrier
000023195 4901_ $$aBio-Science Law Review ;$$v1998/1999 No 5 pages 167-174
000023195 500__ $$a"This article examines the understanding of the exception from patent infringement for 'experimental use relating to the subject-matter of the invention'. It considers the challenge presented by new entrants into the market for patented drugs and also by the use of patented sequences as 'probes'."
000023195 650_0 $$aPatent infringement$$zEurope.
000023195 650_4 $$aEXPERIMENTAL USE : EXCEPTION TO PATENT INFRINGEMENT
000023195 650_4 $$aPHARMACEUTICALS : PATENTED DRUGS : GENERIC ENTRANTS
000023195 650_4 $$aPATENTS : INFRINGEMENT AND CIVIL AND CRIMINAL SANCTIONS : INFRINGEMENT, PATENT FRAUD
000023195 650_4 $$aEXPERIMENTAL USE : BIOTECHNOLOGY
000023195 650_4 $$aPATENT TERM EXTENSION : EUROPE
000023195 651_0 $$aEurope$$xCommerce$$xLaw and legislation.
000023195 830_0 $$aBio-Science Law Review ;$$v1998/1999 No 5 pages 167-174.
000023195 903__ $$v1$$aBIO-SCIENCE LAW REVIEW
000023195 904__ $$aJournal article
000023195 942__ $$cART$$2ddc
000023195 952__ $$w2006-11-03$$p1999-1334$$r0.00$$u36415$$bMAIN$$10$$kGB 110$$v1999-07-14$$zLibrary$$70
000023195 980__ $$aBIB
000023195 999__ $$c25334$$d25334